Skip to main content
IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
0.257
-0.020 (-7.12%)
At close: Apr 28, 2026, 4:00 PM EDT
0.255
-0.002 (-0.74%)
After-hours: Apr 28, 2026, 7:50 PM EDT

IM Cannabis Revenue

In the year 2025, IM Cannabis had annual revenue of 54.73M CAD with 1.30% growth. IM Cannabis had revenue of 15.68M in the quarter ending December 31, 2025, with 17.62% growth.

Revenue (ttm)
54.73M CAD
Revenue Growth
+1.30%
P/S Ratio
0.04
Revenue / Employee
576,116 CAD
Employees
95
Market Cap
1.60M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202554.73M700.00K1.30%
Dec 31, 202454.03M5.23M10.71%
Dec 31, 202348.80M-5.53M-10.18%
Dec 31, 202254.34M20.28M59.56%
Dec 31, 202134.05M18.16M114.30%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sunshine Biopharma 36.31M
cbdMD 19.09M
Universe Pharmaceuticals INC 17.86M
Sonoma Pharmaceuticals 17.72M
InMed Pharmaceuticals 4.51M
China SXT Pharmaceuticals 1.54M
Akanda 836.66K
RedHill Biopharma 286.00K
Revenue Rankings

IMCC News

More News